Actively Recruiting
Study of Metabolic Control and Quality of Life in Phenylketonuria Patients Aged 10 Years and Older Receiving Dietary or Drug Treatment
Led by University Children's Hospital, Zurich · Updated on 2025-04-13
200
Participants Needed
1
Research Sites
39 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to understand how different treatment guidelines affect metabolic control and quality of life in patients with phenylketonuria PKU, a condition requiring careful dietary or pharmacological management. It focuses on how patients adhere to their treatment plans and how this impacts their well-being and family burden, especially since strict diets can be challenging and affect daily life. The study is observational and sponsored by the University Childrens Hospital, Zurich. Participants include patients with PKU aged 10 years and older who follow dietary andor pharmacological treatments based on local guidelines. Parents of patients aged 10 to 18 years may also participate. The study involves no intervention or change to current treatment but collects data from centers following varying guidelines to compare outcomes. During the study, researchers will review phenylalanine Phe levels from the past 24 months and assess health-related quality of life, self-efficacy, and family burden through questionnaires. The study requires participants to be able and willing to complete these questionnaires and follow study procedures. The total duration and specific visits are not detailed, but assessments will take about one hour each. Safety monitoring and long-term follow-up are not specified.
CONDITIONS
Brief Title
Metabolic Control and Patient Well-being in Phenylketonuria: do Guidelines Make a Difference?
Research Team
M
Martina Huemer, Prof
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here